Michael Laffan

14.4k citations
232 papers · 10.3k · 5 hit papers · h-index 53

Impact in

  • Hematology top 0.1%
    • Platelet Disorders and Treatments
    • Hemophilia Treatment and Research
    • Blood Coagulation and Thrombosis Mechanisms
    • Blood groups and transfusion
    • Venous Thromboembolism Diagnosis and Management

Papers in

    • Platelet Disorders and Treatments 69
    • Hemophilia Treatment and Research 50
    • Blood Coagulation and Thrombosis Mechanisms 40
    • Blood groups and transfusion 15
    • Venous Thromboembolism Diagnosis and Management 36

Michael Laffan

218 papers receiving 9.9k citations

Michael Laffan's Hit Papers

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A 2023 · 163 citations
1630+3+6Years since publication200400600

Peers

Michael Laffan
Comparison fields: 5 of 162
  • Hematology 4.6k
  • Internal Medicine 638
  • Genetics 1.3k
  • Genetics 1.6k
  • Critical Care and Intensive Care Medicine 244
Replace Barbara A. Konkle with:
Barbara A. Konkle United States
Alok Srivastava India
Jan Rosing Netherlands
Uri Seligsohn Israel
Hans F. Schwarz Austria
Nejat Akar Türkiye
Flora Peyvandi Italy
Birger Åstedt Sweden
David Launay France
Chia‐Jen Liu Taiwan
Michael Laffan relative to Barbara A. Konkle United States Barbara A. Konkle's profile →
Citations per field
00.5×1.5×
Barbara A. Konkle · 1×
Citations per year

Countries citing papers authored by Michael Laffan

Since Specialization
Citations

This map shows the geographic impact of Michael Laffan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Laffan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Laffan more than expected).

Fields of papers citing papers by Michael Laffan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Laffan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Laffan. The network helps show where Michael Laffan may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Laffan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Laffan Line = papers co-authored together Michael Laffan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity
Hit paper breakdown →
2016721
2
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
Hit paper breakdown →
2017586
3
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
Hit paper breakdown →
2020387
4 2016379
5 2001263
6 2014241
7
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
Hit paper breakdown →
2021235
8 2015195
9 1997191
10 2014186
11 2000179
12 2019174
13 2020174
14 2019172
15
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Hit paper breakdown →
2023163
16 2016158
17 2016155
18 2012140
19 2004132
20 2016131

About Michael Laffan

Michael Laffan is a scholar working on Hematology, Internal Medicine, Genetics, Immunology and Critical Care and Intensive Care Medicine, having authored 232 papers that have together received 10.3k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (69 papers), Hemophilia Treatment and Research (50 papers), Blood Coagulation and Thrombosis Mechanisms (40 papers), Venous Thromboembolism Diagnosis and Management (36 papers), Blood groups and transfusion (15 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (12 papers). The work is most often cited by research in Hematology (4.6k citations), Internal Medicine (638 citations), Genetics (1.3k citations), Genetics (1.6k citations) and Critical Care and Intensive Care Medicine (244 citations). Michael Laffan has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include James S. O’Donnell, Richard A. Manning, John Pasi, Will Lester, Savita Rangarajan, Bella Madan, Wing Yen Wong, Glenn F. Pierce, David John Perry and AM Randi. Their work appears in journals such as Blood, British Journal of Haematology, Haemophilia, Journal of Thrombosis and Haemostasis and Blood Coagulation & Fibrinolysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact